检索历史清除

首页> Blood: The Journal of the American Society of Hematology> Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged >= 65 Years with Acute Myeloid Leukemia

Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged >= 65 Years with Acute Myeloid Leukemia

导出原文传递

翻译打印收藏纠错

作者： Wei, Andrew ; Strickland, Stephen A. ; Roboz, Gail J. ; Hou, Jing-Zhou ; Fiedler, Walter ; Lin, Tara L. ; Martinelli, Giovanni ; Walter, Roland B. ; Enjeti, Anoop ; Fakouhi, Kaffa ; Darden, David E. ; Dunbar, Martin ; Zhu, Ming ; Agarwal, Suresh ; Salem, Ahmed H. ; Mabry, Mack ; Hayslip, John

发布时间 2020-08-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交